Evaluating the relationship of affinity, functional avidity, and in vivo potency in KIR-CAR T cells

被引：0
|
作者：
Xu, Jun
Nunez-Cruz, Selene
Leferovich, John M.
Gulendran, Gayathri
Zhang, Chune
Yucel, Nora D.
Blair, Megan C.
Stanley, William S.
Johnson, Laura A.
Siegel, Don L.
Milone, Michael C.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-6332
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6332
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Immune Signature of Enhanced Functional Avidity CD8+ T Cells in vivo Induced by Vaccinia Vectored Vaccine
    Hu, Zhidong
    Zhu, Lingyan
    Wang, Jing
    Wan, Yanmin
    Yuan, Songhua
    Chen, Jian
    Ding, Xiangqing
    Qiu, Chenli
    Zhang, Xiaoyan
    Qiu, Chao
    Xu, Jianqing
    SCIENTIFIC REPORTS, 2017, 7
  • [22] The Quest for the Best: How TCR Affinity, Avidity, and Functional Avidity Affect TCR-Engineered T-Cell Antitumor Responses
    Campillo-Davo, Diana
    Flumens, Donovan
    Lion, Eva
    CELLS, 2020, 9 (07)
  • [23] CAR Cells beyond Classical CAR T Cells: Functional Properties and Prospects of Application
    Minina, Elizaveta P.
    Dianov, Dmitry V.
    Sheetikov, Saveliy A.
    Bogolyubova, Apollinariya V.
    BIOCHEMISTRY-MOSCOW, 2024, 89 (05) : 765 - 783
  • [24] DESIGNER CAR TRANSMEMBRANE DOMAINS PROVIDE PREDICTABLY TUNABLE T CELL FUNCTIONAL POTENCY
    Call, M.
    Elazar, A.
    Chandler, N.
    Davey, A.
    Weinstein, J.
    Trenker, R.
    Nguyen, J.
    Cross, R.
    Jenkins, M.
    Call, M.
    Fleishman, S.
    HUMAN GENE THERAPY, 2023, 34 (21-22) : A29 - A29
  • [25] Inosine induces stemness features in CAR-T cells and enhances potency
    Klysz, Dorota D.
    Fowler, Carley
    Malipatlolla, Meena
    Stuani, Lucille
    Freitas, Katherine A.
    Chen, Yiyun
    Meier, Stefanie
    Daniel, Bence
    Sandor, Katalin
    Xu, Peng
    Huang, Jing
    Labanieh, Louai
    Keerthi, Vimal
    Leruste, Amaury
    Bashti, Malek
    Mata-Alcazar, Janette
    Gkitsas, Nikolaos
    Guerrero, Justin A.
    Fisher, Chris
    Patel, Sunny
    Asano, Kyle
    Patel, Shabnum
    Davis, Kara L.
    Satpathy, Ansuman T.
    Feldman, Steven A.
    Sotillo, Elena
    Mackall, Crystal L.
    CANCER CELL, 2024, 42 (02) : 266 - 282.e8
  • [26] Defining potency of CAR+ T cells: Fast and furious or slow and steady
    Liadi, Ivan
    Singh, Harjeet
    Romain, Gabrielle
    Roysam, Badrinath
    Cooper, Laurence J. N.
    Varadarajan, Navin
    ONCOIMMUNOLOGY, 2019, 8 (10):
  • [27] In Vivo Generation of CAR T Cells in Presence of Human Myeloid Cells
    Ho, Naphang
    Agarwal, Shiwani
    Milani, Michela
    Cantore, Alessio
    Buchholz, Christian
    Thalheimer, Frederic
    MOLECULAR THERAPY, 2022, 30 (04) : 177 - 178
  • [28] In vivo generation of CAR T cells in the presence of human myeloid cells
    Ho, Naphang
    Agarwal, Shiwani
    Milani, Michela
    Cantore, Alessio
    Buchholz, Christian J.
    Thalheimer, Frederic B.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2022, 26 : 144 - 156
  • [29] In vivo generated human CAR T cells eradicate tumor cells
    Agarwal, Shiwani
    Weidner, Tatjana
    Thalheimer, Frederic B.
    Buchholz, Christian J.
    ONCOIMMUNOLOGY, 2019, 8 (12):
  • [30] Functional T Cell Assays Are Predictive of Pre-Clinical Potency to Generate Allogeneic, Hypoimmune CD19 CAR T Cells
    Salloum, Darin
    Tundwal, Kavita
    Kangeyan, Divy
    Johnson, Adam
    van Hoeven, Neal
    Granger, Brian
    Moreno, Jesus
    Liang, Ouwen
    Beauchesne, Pascal
    Fry, Terry J.
    Foster, Aaron
    BLOOD, 2022, 140 : 4524 - 4525
12345